 efficaci azathioprin relapsing-remit multipl sclerosi patient relapsing-remit multipl sclerosi azathioprin aza mg/kg daili placebo double-mask therapeut trial analysi data predetermin primari outcom measur signific differ aza observ mean exacerb rate year therapi time deterior ambul index kurtzk expand disabl statu scale score studi modest therapeut benefit azathioprin investig